Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence summary HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS FPKM FPKM max in non-specific ACKR1 CCBP1, CD234, DARC, Dfy, FY, GPD ENSG00000213088 Atypical chemokine receptor 1 (Duffy blood group) 1 159203307-159206500 Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA016421, HPA017672 Supportive Mixed adipose tissue: 71.9 ACKR2 CCBP2, CCR10, CCR9, CMKBR9, D6 ENSG00000144648 Atypical chemokine receptor 2 3 42804752-42887974 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013819 Supportive Tissue enriched 5 placenta: 16.1 adipose tissue: 3.0 ADRB1 ADRB1R ENSG00000043591 Adrenoceptor beta 1 10 114044056-114046908 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA067972 Supportive Tissue enhanced 0 placenta: 26.0 heart muscle: 8.6 AGTR1 AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R ENSG00000144891 Angiotensin II receptor, type 1 3 148697784-148743008 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA003596 Supportive Group enriched 5 adipose tissue: 28.7;adrenal gland: 34.3;liver: 33.6;placenta: 101.1 kidney: 9.5 CASR FHH, GPRC2A, HHC, HHC1, NSHPT ENSG00000036828 Calcium-sensing receptor 3 122183683-122286503 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039686, HPA050335 Supportive Tissue enhanced 0 gallbladder: 4.9;kidney: 16.8 stomach: 3.2 CCR6 BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22 ENSG00000112486 Chemokine (C-C motif) receptor 6 6 167122769-167139696 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006820, HPA014488 Supportive Tissue enhanced 0 lymph node: 10.1;tonsil: 19.7 spleen: 7.0 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003796 Supportive Group enriched 5 appendix: 57.6;lymph node: 68.9;spleen: 23.6;tonsil: 67.3 urinary bladder: 9.9 CD97 TM7LN1 ENSG00000123146 CD97 molecule 19 14380501-14408725 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013707 Supportive Uncertain Cytoplasm Expressed in all bone marrow: 104.5 CHRM1 ENSG00000168539 Cholinergic receptor, muscarinic 1 11 62908679-62921807 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014101, CAB022366 Supportive Uncertain Nucleus, Cytoplasm Group enriched 8 cerebral cortex: 19.6;prostate: 23.5;salivary gland: 12.0 adrenal gland: 2.3 CXCR2 CD182, CMKAR2, IL8RB ENSG00000180871 Chemokine (C-X-C motif) receptor 2 2 218125289-218137253 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016268, HPA031999, HPA032017 Supportive Tissue enhanced 0 appendix: 33.0;esophagus: 22.4 spleen: 20.6 CXCR3 CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR ENSG00000186810 Chemokine (C-X-C motif) receptor 3 X 71615916-71618517 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045942 Supportive Tissue enhanced 0 lymph node: 12.5 spleen: 6.0 CXCR5 BLR1, CD185, MDR15 ENSG00000160683 Chemokine (C-X-C motif) receptor 5 11 118883766-118897799 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026149, HPA042432 Supportive Group enriched 5 appendix: 8.9;bone marrow: 5.2;lymph node: 23.2;spleen: 14.9;tonsil: 14.1 urinary bladder: 2.6 DRD5 DRD1B, DRD1L2 ENSG00000169676 Dopamine receptor D5 4 9781680-9784009 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA048930 Supportive Group enriched 8 appendix: 1.1;cerebral cortex: 0.9 prostate: 0.1 EDNRA ENSG00000151617 Endothelin receptor type A 4 147480917-147544954 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013774, HPA014087, CAB018957 Supportive Uncertain Cytoplasm, Nucleus but not nucleoli, Plasma membrane Mixed endometrium: 40.4 ELTD1 ETL ENSG00000162618 EGF, latrophilin and seven transmembrane domain containing 1 1 78889764-79006718 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA025229 Supportive Mixed adipose tissue: 44.8 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288109-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supportive Tissue enriched 14 cerebral cortex: 45.8 adrenal gland: 3.1 GLP2R ENSG00000065325 Glucagon-like peptide 2 receptor 17 9822206-9892102 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA049244 Supportive Tissue enhanced 0 gallbladder: 11.2 duodenum: 7.7 GPR113 hGPCR37, PGR23 ENSG00000173567 G protein-coupled receptor 113 2 26308173-26346817 G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA044500 Supportive Tissue enhanced 0 kidney: 0.6 spleen: 0.2 GPR123 KIAA1828 ENSG00000197177 G protein-coupled receptor 123 10 133070929-133131675 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042773 Supportive Tissue enhanced 0 adrenal gland: 2.9;cerebral cortex: 10.0 fallopian tube: 1.9 GPR132 G2A ENSG00000183484 G protein-coupled receptor 132 14 105049389-105065445 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA029694, HPA029695 Supportive Supportive Nucleus but not nucleoli, Cytoplasm, Centrosome Mixed lymph node: 6.5 GPR135 HUMNPIIY20, PAFR ENSG00000181619 G protein-coupled receptor 135 14 59429022-59465342 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA045337 Supportive Tissue enhanced 0 testis: 4.4 fallopian tube: 3.3 GPR160 GPCR1, GPCR150 ENSG00000173890 G protein-coupled receptor 160 3 170037929-170085403 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA006970 Supportive Supportive Plasma membrane Mixed small intestine: 86.6 GPR162 A-2, GRCA ENSG00000250510 G protein-coupled receptor 162 12 6821545-6829972 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA055135 Supportive Uncertain Microtubule organizing center Tissue enhanced 0 cerebral cortex: 38.8 fallopian tube: 17.6 GPR182 ADMR, AM-R, G10D, hrhAMR ENSG00000166856 G protein-coupled receptor 182 12 56994446-56996684 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA027037 Supportive Tissue enriched 7 spleen: 7.9 lymph node: 1.1 GPR37L1 ETBR-LP-2 ENSG00000170075 G protein-coupled receptor 37 like 1 1 202122858-202133592 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064454 Supportive Tissue enriched 45 cerebral cortex: 17.6 colon: 0.3 GPR61 BALGR ENSG00000156097 G protein-coupled receptor 61 1 109539872-109548406 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA007326, HPA026088 Supportive Uncertain Nucleus but not nucleoli, Cytoplasm Tissue enhanced 0 cerebral cortex: 1.6;thyroid gland: 0.7 adrenal gland: 0.6 HCRTR2 OX2R ENSG00000137252 Hypocretin (orexin) receptor 2 6 55106460-55282620 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA054516 Supportive Not detected cerebral cortex: 0.2 HTR2A 5-HT2A, HTR2 ENSG00000102468 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13 46831550-46897076 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014011 Supportive Tissue enriched 7 cerebral cortex: 16.9 smooth muscle: 2.3 NPSR1 GPR154, GPRA, PGR14 ENSG00000187258 Neuropeptide S receptor 1 7 34658239-34878332 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA007489 Supportive Tissue enhanced 0 stomach: 0.5 testis: 0.1 OPRM1 MOR1 ENSG00000112038 Opioid receptor, mu 1 6 154010496-154246867 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014509, HPA067435 Supportive Supportive Tissue enhanced 0 adrenal gland: 0.9;testis: 1.8 cerebral cortex: 0.3 P2RY12 HORK3, P2Y12, SP1999 ENSG00000169313 Purinergic receptor P2Y, G-protein coupled, 12 3 151337380-151384812 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013796, HPA014518 Supportive Tissue enhanced 0 cerebral cortex: 37.7 lymph node: 8.3 P2RY13 FKSG77, GPR86, GPR94, P2Y13 ENSG00000181631 Purinergic receptor P2Y, G-protein coupled, 13 3 151326312-151329548 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049047 Supportive Tissue enhanced 0 spleen: 29.3 appendix: 19.7